To facilitate drug discovery combating immunosuppressive pancreatic ductal adenocarcinoma, a high-throughput drug screen platform was established with the newly developed T cell-incorporated pancreatic tumor organoid model.
[Advanced Science]
Home Newsletters Immune Regulation News A T Cell-Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
